← Leaderboards
Shivendra Singh
University Of Pittsburgh At Pittsburgh
$26,555,479
Attributed
$26,710,461
Total exposure
13
Grants
9
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $1.6M · FY2005–23$2M$1.5M$1M$500K$0
'05
'06
'07
'08
'09
'10
'11
'12
'13
'14
'15
'16
'17
'18
'19
'20
'21
'22
'23
Funding mix
By agency
NIH$26,710,461 · 13
By mechanism
R01$26,694,461 · 12
R13$16,000 · 1
Top collaborators
- Zhou Wang1 shared
Most similar at University Of Pittsburgh At Pittsburgh
Same institution · by research overlap
- Dong Xiao$963,746
- Rebecca J Leeman$133,834
- Zhou Wang$17,521,825
Others in their field
Top investigators on “Cessation Of Life”
- David R. Weir · University Of Michigan At Ann Arbor$345,522,974
- John M Lachin · George Washington University$134,302,892
- David M Nathan · Massachusetts Institute Of Technology$127,791,564
- Judith S Hochman · New York University School Of Medicine$112,898,313
- Jeffrey H Samet · Boston University Medical Campus$91,739,367
- Judith S. Currier · University Of California Los Angeles$85,330,415
Research focus
Cessation Of LifeIn VivoMediatingCancer EtiologyChemopreventive AgentCellsChemopreventionMalignant NeoplasmsDesignTransgenic MiceClinical TrialsMolecularBaseFutureApoptosisIncidenceMouse ModelTumor TissueMitochondriaResearch Project GrantsResponseReactive Oxygen SpeciesPre-ClinicalDown-Regulation
Grant awards (90)
Biomarkers of Sulforaphane/Broccoli Sprout Extract in Prostate Cancer$428,151
R01 · FY2023 · CA · contact PI
The Role of FoxQ1 in Breast Cancer Chemoprevention by Allium Constituents - R01CA219180$350,834
R01 · FY2023 · CA · contact PI
Biomarkers of Sulforaphane/Broccoli Sprout Extract in Prostate Cancer$660,532
R01 · FY2022 · CA · contact PI
The Role of FoxQ1 in Breast Cancer Chemoprevention by Allium Constituents - R01CA219180$350,834
R01 · FY2022 · CA · contact PI
Biomarkers of Sulforaphane/Broccoli Sprout Extract in Prostate Cancer$480,187
R01 · FY2021 · CA · contact PI
The Role of FoxQ1 in Breast Cancer Chemoprevention by Allium Constituents - R01CA219180$357,994
R01 · FY2021 · CA · contact PI
Biomarkers of Sulforaphane/Broccoli Sprout Extract in Prostate Cancer$219,491
R01 · FY2021 · CA · contact PI
Biomarkers of Sulforaphane/Broccoli Sprout Extract in Prostate Cancer$530,798
R01 · FY2020 · CA · contact PI
The Role of FoxQ1 in Breast Cancer Chemoprevention by Allium Constituents - R01CA219180$357,994
R01 · FY2020 · CA · contact PI
Biomarkers of Sulforaphane/Broccoli Sprout Extract in Prostate Cancer$494,138
R01 · FY2019 · CA · contact PI
The Role of FoxQ1 in Breast Cancer Chemoprevention by Allium Constituents - R01CA219180$357,994
R01 · FY2019 · CA · contact PI
Anticarcinogenic Effect of ITCs Against Prostate Cancer$336,105
R01 · FY2019 · CA · contact PI
Breast Cancer Prevention by Ayurvedic Medicine Constituents$336,105
R01 · FY2019 · CA · contact PI
Breast Cancer Prevention by Ayurvedic Medicine Constituents$346,500
R01 · FY2018 · CA · contact PI
Anticarcinogenic Effect of ITCs Against Prostate Cancer$346,500
R01 · FY2018 · CA · contact PI
Anticarcinogenic Effect of ITCs Against Prostate Cancer$346,500
R01 · FY2017 · CA · contact PI
Breast Cancer Prevention by Ayurvedic Medicine Constituents$346,500
R01 · FY2017 · CA · contact PI
Breast Cancer Prevention by Ayurvedic Medicine Constituents$346,500
R01 · FY2016 · CA · contact PI
Anticarcinogenic Effect of ITCs Against Prostate Cancer$346,500
R01 · FY2016 · CA · contact PI
Breast Cancer Prevention by Dietary Phytochemicals$282,328
R01 · FY2016 · CA · contact PI
Breast Cancer Prevention by Ayurvedic Medicine Constituents$346,500
R01 · FY2015 · CA · contact PI
Anticarcinogenic Effect of ITCs Against Prostate Cancer$346,500
R01 · FY2015 · CA · contact PI
Prevention of Prostate Cancer by Sulforaphane$283,708
R01 · FY2015 · CA · contact PI
Breast Cancer Prevention by Dietary Phytochemicals$282,372
R01 · FY2015 · CA · contact PI
Mechanistic Studies on Prostate Cancer Prevention by Gugulipid$309,964
R01 · FY2014 · CA
Prostate Cancer Prevention by Diallyl Trisulfide$309,316
R01 · FY2014 · CA · contact PI
Breast Cancer Prevention by Ayurvedic Medicine Constituents$295,784
R01 · FY2014 · CA · contact PI
Prevention of Prostate Cancer by Sulforaphane$275,197
R01 · FY2014 · CA · contact PI
Breast Cancer Prevention by Dietary Phytochemicals$273,721
R01 · FY2014 · CA · contact PI
Anticarcinogenic Effect of ITCs Against Prostate Cancer$300,172
R01 · FY2013 · CA · contact PI
Prostate Cancer Prevention by Diallyl Trisulfide$299,750
R01 · FY2013 · CA · contact PI
Breast Cancer Prevention by Ayurvedic Medicine Constituents$286,637
R01 · FY2013 · CA · contact PI
Prevention of Prostate Cancer by Sulforaphane$266,685
R01 · FY2013 · CA · contact PI
Breast Cancer Prevention by Dietary Phytochemicals$262,945
R01 · FY2013 · CA · contact PI
Anticarcinogenic Effect of ITCs Against Prostate Cancer$319,332
R01 · FY2012 · CA · contact PI
Prostate Cancer Prevention by Diallyl Trisulfide$318,883
R01 · FY2012 · CA · contact PI
Breast Cancer Prevention by Ayurvedic Medicine Constituents$304,932
R01 · FY2012 · CA · contact PI
Prevention of Prostate Cancer by Sulforaphane$283,708
R01 · FY2012 · CA · contact PI
Breast Cancer Prevention by Dietary Phytochemicals$279,768
R01 · FY2012 · CA · contact PI
Anticarcinogenic Effect of ITCs Against Prostate Cancer$319,332
R01 · FY2011 · CA · contact PI
Prostate Cancer Prevention by Diallyl Trisulfide$318,883
R01 · FY2011 · CA · contact PI
Breast Cancer Prevention by Ayurvedic Medicine Constituents$304,932
R01 · FY2011 · CA · contact PI
Prevention of Prostate Cancer by Sulforaphane$283,708
R01 · FY2011 · CA · contact PI
Breast Cancer Prevention by Dietary Phytochemicals$273,686
R01 · FY2011 · CA · contact PI
Anticarcinogenic Effect of ITCs Against Prostate Cancer$329,208
R01 · FY2010 · CA · contact PI
Breast Cancer Prevention by Ayurvedic Medicine Constituents$314,363
R01 · FY2010 · CA · contact PI
Breast Cancer Prevention by Dietary Phytochemicals$282,150
R01 · FY2010 · CA · contact PI
Prostate Cancer Prevention by Diallyl Trisulfide$146,110
R01 · FY2010 · CA · contact PI
Anticarcinogenic Effect of ITCs Against Prostate Cancer$329,208
R01 · FY2009 · CA · contact PI
Breast Cancer Prevention by Dietary Phytochemicals$282,150
R01 · FY2009 · CA · contact PI
Prevention of Prostate Cancer by Sulforaphane$276,934
R01 · FY2009 · CA · contact PI
Prostate Cancer Prevention by Diallyl Trisulfide$276,692
R01 · FY2009 · CA · contact PI
Breast Cancer Prevention by Dietary Phytochemicals$282,150
R01 · FY2008 · CA · contact PI
Prevention of Prostate Cancer by Sulforaphane$276,968
R01 · FY2008 · CA · contact PI
Prostate Cancer Prevention by Diallyl Trisulfide$276,733
R01 · FY2008 · CA · contact PI
Anticarcinogenic Effect of ITCs Against Prostate Cancer$312,472
R01 · FY2007 · CA · contact PI
Breast Cancer Prevention by Dietary Phytochemicals$282,150
R01 · FY2007 · CA · contact PI
Prevention of Prostate Cancer by Sulforaphane$277,000
R01 · FY2007 · CA · contact PI
Prostate Cancer Prevention by Diallyl Trisulfide$276,772
R01 · FY2007 · CA · contact PI
Bioactive Food Comoponents, Alternative Medicine and Cancer Chemoprevention: Rece$16,000
R13 · FY2007 · CA · contact PI
Anticarcinogenic Effect of ITCs Against Prostate Cancer$321,804
R01 · FY2006 · CA · contact PI
Prevention of Prostate Cancer by Sulforaphane$286,396
R01 · FY2006 · CA · contact PI
Prostate Cancer Prevention by Diallyl Trisulfide$285,078
R01 · FY2006 · CA · contact PI
Novel GST and Detoxication of Diol Epoxides$272,619
R01 · FY2006 · CA · contact PI
Toxicological Relevance of Human GST P1-1 Polymorphism$373,490
R01 · FY2005 · ES
Anticarcinogenic Effect of ITCs Against Prostate Cancer$329,549
R01 · FY2005 · CA
Prevention of Prostate Cancer by Sulforaphane$293,288
R01 · FY2005 · CA
Prostate Cancer Prevention by Diallyl Trisulfide$291,977
R01 · FY2005 · CA
Novel GST and Detoxication of Diol Epoxides$279,180
R01 · FY2005 · CA
Toxicological Relevance of Human GST P1-1 Polymorphism$362,608
R01 · FY2004 · ES
Anticarcinogenic Effect of ITCs Against Prostate Cancer$329,549
R01 · FY2004 · CA
Novel GST and Detoxication of Diol Epoxides$279,571
R01 · FY2004 · CA
Toxicological Relevance of Human GST P1-1 Polymorphism$352,731
R01 · FY2003 · ES
Anticarcinogenic Effect of ITCs Against Prostate Cancer$326,292
R01 · FY2003 · CA
Novel GST and Detoxication of Diol Epoxides$280,512
R01 · FY2003 · CA
ROLE OF HUMAN GST PI POLYMORPHISM IN DRUG RESISTANCE$235,913
R01 · FY2003 · CA
MECHANISM OF ANTICARCINOGENIC ACTIVITY--ORGANOSULFIDES$200,751
R01 · FY2003 · CA
Toxicological Relevance of Human GST P1-1 Polymorphism$355,691
R01 · FY2002 · ES
ROLE OF HUMAN GST PI POLYMORPHISM IN DRUG RESISTANCE$235,923
R01 · FY2002 · CA
MECHANISM OF ANTICARCINOGENIC ACTIVITY--ORGANOSULFIDES$201,423
R01 · FY2002 · CA
NOVEL GST AND DETOXICATION OF DIOL EPOXIDES$254,130
R01 · FY2001 · CA
ROLE OF HUMAN GST PI POLYMORPHISM IN DRUG RESISTANCE$235,932
R01 · FY2001 · CA
TOXICOLOGICAL RELEVANCE OF HUMAN GST PL-L POLYMORPHISM$204,843
R01 · FY2001 · ES
MECHANISM OF ANTICARCINOGENIC ACTIVITY--ORGANOSULFIDES$202,096
R01 · FY2001 · CA
ROLE OF HUMAN GST PI POLYMORPHISM IN DRUG RESISTANCE$235,942
R01 · FY2000 · CA
NOVEL GST AND DETOXICATION OF DIOL EPOXIDES$231,213
R01 · FY2000 · CA
MECHANISM OF ANTICARCINOGENIC ACTIVITY--ORGANOSULFIDES$224,708
R01 · FY2000 · CA
TOXICOLOGICAL RELEVANCE OF HUMAN GST PL-L POLYMORPHISM$136,939
R01 · FY2000 · ES
TOXICOLOGICAL RELEVANCE OF HUMAN GST PL-L POLYMORPHISM$72,041
R01 · FY2000 · ES
NOVEL GST AND DETOXICATION OF DIOL EPOXIDES$12,312
R01 · FY2000 · CA